Evidence map›Paper›PMID 29861423›Full record

ArticleNon-coding RNA2015

Epstein-Barr Virus EBER Transcripts Affect miRNA-Mediated Regulation of Specific Targets and Are Processed to Small RNA Species.

Julia Alles, Daniele Hasler, Syed Mohammad Ali Kazmi, Mathias Tesson, Andrew Hamilton, Linda Schlegel, Stefanie Marx, Norbert Eichner, Richard Reinhardt, Gunter Meister and 2 more

Open access · goldAbstract read
In one paragraph

Article in Non-coding RNA, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Julia AllesInstitute of Virology, Saarland University Medical School, Kirrbergerstrasse, Haus 47, Homburg/Saar D-66421, Germany. ju.al@mx.uni-saarland.de.
Daniele HaslerBiochemistry Center Regensburg (BZR), Laboratory for RNA Biology, University of Regensburg, Universitätsstrasse 31, Regensburg D-93053, Germany. Daniele.Hasler@vkl.uni-regensburg.de.
Syed Mohammad Ali KazmiCollege of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK. alikazmi39@gmail.com.
Mathias TessonCollege of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK. Mathias.Tesson@glasgow.ac.uk.
Andrew HamiltonCollege of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK. Andrew.Hamilton@glasgow.ac.uk.
Linda SchlegelInstitute of Virology, Saarland University Medical School, Kirrbergerstrasse, Haus 47, Homburg/Saar D-66421, Germany. lindaschlegel@gmx.de.
Stefanie MarxInstitute of Virology, Saarland University Medical School, Kirrbergerstrasse, Haus 47, Homburg/Saar D-66421, Germany. stefanie.marx@uks.eu.
Norbert EichnerBiochemistry Center Regensburg (BZR), Laboratory for RNA Biology, University of Regensburg, Universitätsstrasse 31, Regensburg D-93053, Germany. Norbert.Eichner@vkl.uni-regensburg.de.
Richard ReinhardtMax Planck Genome Centre Cologne, Carl-von-Linné-Weg 10, Cologne D-50829, Germany. reinhardt@mpipz.mpg.de.
Gunter MeisterBiochemistry Center Regensburg (BZR), Laboratory for RNA Biology, University of Regensburg, Universitätsstrasse 31, Regensburg D-93053, Germany. Gunter.Meister@vkl.uni-regensburg.de.
Joanna B WilsonCollege of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK. joanna.wilson@glasgow.ac.uk.
Friedrich A GrässerInstitute of Virology, Saarland University Medical School, Kirrbergerstrasse, Haus 47, Homburg/Saar D-66421, Germany. graesser@uks.eu.
Saarland University · DEUniversity of Glasgow · GBUniversity of Regensburg · DEMax Planck Institute for Plant Breeding Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oncogenic Epstein-Barr virus (EBV) expresses 44 mature microRNAs and two non-coding EBER RNAs of 167 (EBER1) and 172 (EBER2) nt length. MiRNA profiling of NK/T cell lines and primary cells and Northern blotting of EBV-infected cell lines and primary tumors revealed processing of EBER1 to short 5'-derived RNAs of approximately 23, 52 and 70 nt (EBER123, EBER152, and EBER170) and of EBER2 to 3' fragments. The biogenesis of these species is independent of Dicer, and EBER123 does not act like a miRNA OPEN ACCESS Non-Coding RNA 2015, 1 171 to target its complementary sequence. EBER1, EBER2 and EBER123 were bound by the lupus antigen (La), a nuclear and cytoplasmic protein that facilitates RNAi. Consistent with this, the EBERs affect regulation of interleukin 1alpha (IL1α) and RAC1 reporters harboring miR target sequences, targets of miR-142-3p. However, the EBERs have no effect upon another target of miR-142-3p, ADCY9, nor on TOMM22, a target of ebv-miR-BART16, indicative of selective modulation of gene expression by the EBERs.

Indexed as

ADCY9DICEREBEREBVebv-miR-BART16Epstein-Barr virushsa-miR-142IL1ALaLupus antigenmicroRNARAC1TOMM22

Identifiers

PMID29861423
PMCPMC5932547
OpenAlexW1539353539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.